Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

Corbus Pharmaceuticals is dedicated to developing therapies for cancer and obesity through cutting-edge research and compassionate care. Explore our pipeline of investigational treatments aimed at improving patient outcomes and quality of life.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
84 portfolio companies: Cookiedatabase.org, Businessitessentials, Nano-C >> and 81 more

News

Corbus Pharmaceuticals stock holds at USD 1.56
Corbus Pharmaceuticals stock closed at USD 1.56 on September 21, 2026, down USD 0.05 from the prior session. Nasdaq volume reached 70,018 shares.
Read more
Report
News RTTNews 2 months ago
Corbus Announces Positive Phase 1b Weight-Loss Data Showing For Oral Candidate CRB-913; Stock Up
Corbus Pharmaceuticals Holdings, Inc. (CRBP), announced positive topline results from its CANYON-1 Phase 1b study evaluating daily oral CRB-913 for obesity, with the 60 mg dose achieving statistically significant and clinically meaningful mean weight loss
Read more
Report
News YahooFinance 2 months ago
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
CRB-913 demonstrated statistically significant and clinically meaningful mean weight loss of 5% at 60 mg after 12 weeks with no plateau observedCRB-913 was generally well tolerated with psychiatric adverse events broadly in line with GLP-1 drugs and a fav
Read more
Report
News YahooFinance 2 months ago
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Virtual Webcast to be Held Monday, September 14, 2026, at 8:00 AM EDTNORWOOD, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing new therapies in oncology and obes
Read more
Report
News facebookapp 5 months ago
Corbus Pharma Norwood MA
Corbus Pharma, Norwood. 35,390 followers 66 talking about this 9 were here. Corbus (Nasdaq: CRBP) is connecting innovation to purpose to improve the futures of cancer and obesity patients.
Read more
Report
News Nasdaq 3 years ago
Is Corbus Pharmaceuticals (CRBP) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Corbus Pharmaceuticals (CRBP) been one of those stocks this year? By taking a look at the s
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Corbus Pharmaceuticals, Inc over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
4
Stack modernity
53/100
Cloud & platforms
GCP
Developer tools
Microsoft Excel
Veeva
Practices & domains
Good Clinical Practice
CAPA
GMP
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
22/100
Hiring freeze
Open positions
3
0 opened / 0 closed in 30 days
Median time-to-fill
75 days
faster than 16% of the market
ATS activity
Every ~6 hours
11/01/2026
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
75% ▲
Industrial Engineering
25% ▼

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Norwood
Norwood United States
Regional office
Corbus Pharmaceuticals, Inc
2 open roles 3 posted in 90 days
hires for Biotech
500 River Ridge Drive, Norwood, MA 02062
seen since Aug 2026 company site, job postings

Jobs

≈ $170k – $295k per year (Estimated) · In office · Full-Time · 15+ years exp · PhD · Norwood
GMP
Apply
≈ $119k – $209k per year (Estimated) · Hybrid · Full-Time · 8+ years exp · Bachelor's Degree · United States
GCP
Life Sciences
Good Clinical Practice
MedTech
CAPA
Apply
≈ $184k – $321k per year (Estimated) · Hybrid · 10+ years exp · Bachelor's Degree · Norwood
Good Clinical Practice
Apply